Updated on 30 August 2016
(Photo Courtesy: www.coastalclinic.com)
In 2015, North America accounted for the largest revenue share of global regenerative medicine (bone & joints) market, representing a market value of $ 2,039.8 million.
Owing to increasing demand for bone and joint reconstructive surgeries and encouraging government initiatives, North America is expected to remain the largest market for regenerative medicine (bone and joint) in 2016.
Europe is the second largest market for regenerative medicine, with the region's high geriatric population fuelling adoption at a robust pace.
By technology, biomaterials segment accounts for the highest market share globally, owing to favorable reimbursement policies and strong demand for biomaterials.
Apart from biomaterials, tissue engineering is the other segment which is quickly gaining traction among end-users, and is projected to witness the highest YoY growth among all the technology segments.